Navigating The Use Of Controlled Substances In Clinical Trials Using IRT
Sponsor organizations that want to use controlled substances in clinical studies must manage the associated regulatory and logistical requirements. This can be challenging for Emerging BioPharmas with smaller staffs and fewer resources. Regardless of size, every sponsor must use extreme care to meet geographic regulations for the use and distribution of controlled substances in studies.
Cenduit’s leading team of experts in global regulatory compliance and quality build highly configurable and adaptable IRT systems that can easily manage the many requirements of using controlled substances – whether in the U.S., or any other country. Clients receive the confidence of consistent compliance for their supply chain, drug management, and dosing practices.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.